Ugur Sahin

Country: Germany
Company: University Medical Center Mainz
Dr. Ugur Sahin is a German-Turkish immunologist and the co-founder of BioNTech, a biotechnology company that partnered with Pfizer to develop one of the world's first authorized mRNA-based COVID-19 vaccines. He has invested in Moderna Therapeutics and BioNTech who stated that vaccines to treat cancer possible by 2030.
Claim Profile
sahin@uni-mainz.de
https://www.linkedin.com/in/ugur-sahin-65905917/